6GC-13170-98016
2 vaccinations
4 coded responses
18 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 466 / IN
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- FMJ-22951-41525
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-30
Registered in v-safe
-
2022-06-30
Dose 1 — Moderna
- 2022-06-30
- 2022-07-02
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-08
- 2022-07-21
-
2022-07-27
Dose 2 — Moderna
-
2022-07-28
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-07-30
- 2022-08-02
- 2022-08-06
- 2022-08-12
-
2022-08-17
Survey response — day 21, dose 2, under 3MedDRA: Fatigue, Rhinorrhoea — Feeling: GoodFree text: Runny nose and fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-08-25
Survey response — day 28, dose 2, under 3MedDRA: Middle ear effusion, Pre-existing disease, Sinus congestion — Feeling: GoodFree text: Sinus congestion resulting in fluid from ears. This could likely be attributed to seasonal allergies.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-31
- 2022-09-07
-
2022-10-26
Survey response — 3 months, dose 2, under 3MedDRA: Nasal congestion, Pyrexia — Feeling: Fair · Be unable to work or attend schoolFree text: Low grade fever and stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2023-01-25
Survey response — 6 months, dose 2, under 3MedDRA: Cough, Pyrexia, Respiratory symptom, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-30 | Moderna | No |
| 2 | 2022-07-27 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Runny nose and fatigue
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Sinus congestion resulting in fluid from ears. This could likely be attributed to seasonal allergies.
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Low grade fever and stuffy nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Middle ear effusion | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release